DESPINA SIOLAS

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology NEW YORK, NY NPI 1598083552

General Payments — all program years on this page

$4,907.92

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 28
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,550.33 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $2,200.002
Food and Beverage $350.3313

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $142.892
2020 $136.351
2021 $1,800.002
2022 $156.973
2023 $121.385
2024 $2,550.3315

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087344373 Novartis Pharmaceuticals Corporation $31.25 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091977775 Ipsen Biopharmaceuticals, Inc $26.53 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091977777 Ipsen Biopharmaceuticals, Inc $23.59 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091977779 Ipsen Biopharmaceuticals, Inc $25.80 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091977781 Ipsen Biopharmaceuticals, Inc $26.29 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101629348 E.R. Squibb & Sons, L.L.C. $1,675.00 04/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104542432 AstraZeneca Pharmaceuticals LP $525.00 03/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104554268 AstraZeneca Pharmaceuticals LP $24.70 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105797164 AstraZeneca Pharmaceuticals LP $24.62 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105809213 AstraZeneca Pharmaceuticals LP $24.11 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110741655 Eisai Inc. $22.61 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137940414 TAIHO ONCOLOGY, INC. $31.25 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144713929 TerSera Therapeutics LLC $30.76 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144713931 TerSera Therapeutics LLC $28.30 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150222424 JAZZ PHARMACEUTICALS INC. $30.52 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.